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A I'unetionalixcd N.ar~'l .zetidinon¢ ha~t been drown to inactivate human leukt~eyt¢ ela=ta~ [HLE) and porcine panereatle elaMa~¢ (PPE) by an 
enzyme.mediated pro~¢=~. The inactivation is characterized by the t'ollewtn~ kinetic ¢on~ta nt~ at pH tk0 and ~7'C: k,p,.+~ - 0,0~.~ s = z. g~ ~ 1,2 ~ I 0 =* 
M for HLE, 0,08 =t *~ and 2.'1 x 10 ''~ M for PPE, te,tpeetively. Two parent moleeule~¢ dc~voitt or the latent leavintl sroup tidied to inactivate HLE 
and PPE and bchawd as ~ubstrates of these nzymes, A ~uicide mechanism i~ postulated inv~lvinll the formation or an acyl-enxyme and the simuha. 
neous unmaskin$ of a latent quinonimmonium ~thid¢ ion which irrever~ib!y reacts with an active ~it© nudeophil¢. Moreover. the inhibitor t~ 
still ¢fl'~tive at inhibitinlt elasla~ preab~orbed ol~to ela~tin, 
/i.Laetam: Leukocyte ¢lastase; Suicide ~ub~trale 
1. INTRODUCTION 
Human leucocyte lastase (HLE), a serine protease 
released by the azurophilic granules of human 
polymorphonuclear leukocytes (PMN), degrades 
elastin and other connective tissue components [1]. It 
has been implicated in the pathogenesis of pulmonary 
emphysema nd other inflammatory diseases uch as 
rheumatoid arthritis and cystic fibrosis [2,3]. Synthetic 
inhibitors may have value in medicine for controlling 
tissue damage and various inflammatory or 
degenerative conditions mediated by elastase [4,5]. 
Some ~'-lactams such as N-tertiobutyl benzoazetidin. 
one [6] or cephalotin [7] have been reported to be in. 
hibitors of mammalian serine proteases such as 
ce-chymotrypsin. Recently, series of neutral derivatives 
of cephalosporins [8,91 and monocyclic d-lactams [10] 
Abbreviations: HLE, human leukocyte lastase (EC 3.4.21,37); PPE 
porcine pancreatic elastase (EC 3,4.21.36); Suc-AlapNA, succinyl. 
alanyl-alanyl-alanine p-nitroanilide; MeO-Suc-Alaz-Pro-Val.NA, 
methoxysuccinyl-alanyl.alanyl.prolyl.valyl p-nitroanilide; Ac-Tyr- 
NA, N-acetyl-L-tyrosine p-nitroanilide; Bz-Arg-NA, benzoyl.arginyl 
p-nitroanilide; S-2251, D-valyl-L-leucyl-L.lysine p-nitroanilide; 
S-2238, D-pl~enylalanine-L-pipecolyl-L.arginine p-nitroanilide,, 
PNA, p-nitropheayl acetate; NPGB, p-nitrophenyl p-guanidino. 
benzoate; Z-Ala-Ala-Pro-Aala-Ala-ONp, N+benzylo)lycarbonyl.ala- 
nyl-alanyl-prolyl-azaalanyl.p.nitrophenyl ester; DMSO, 
dimethylsulfo×ide 
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have been developed as mechanism-based inhibitors of 
HLE. Previ.ously, we prepared a series of carboxy 
substituted N-aryl azetidinones which behaved as com- 
petitive inhibitors of bacterial serine,~-lactamases [I I],
We have now designed functionalized N-aryI 
azetidinones as mechanism-based inactivators of 
leukocyte elastase. One member of this new family, 
N-(2-chloromethylphenyl) 3,3-difluoro-azetidin-2-one 
(compound 3, Fig. 1) was proven to be efficient at 
preventing the degradation of lung elastic fibers induc- 
ed by elastase [12]. We present here the biochemical ra- 
tionale behind the design of this new series of inhibitors 
of leukocyte lastase and experiments which support a 
mechanism-based process involving a powerful elec- 
trophilic quinonimmonium ethide ion [131 (Fig. 1). In 
comparison; the effect on elastase activity of the un- 
functionalized molecules devoid of the chloride leaving 
group, N-(2-methylphenyl) 3,3-difluoro,azetidin-2- 
ones (compounds I and 2, Fig. 1), is analyzed; The effi- 
ciency of the inhibitor 3 towards elastase preabsorbed 
onto elastin is also examined. 
2. MATERIALS AND METHODS 
2.1. Materials 
PPE, HLE, bovine a-cl~ymotrypsin, bovine trypsin, human 
plasmin and human thrombin were obtained from Serva. Elastin Pro- 
duels Co., Cooper Biochemicals, Sigma, Kabi Vitrum and 
Boehringer-Mannheim, respectively. The commercial sources of the 
eliromogenie substrates were Sigma (Suc-AlarNA for PPE), Baehem 
(MeO-Suc-Ala:-Pro-Val-NA for HLE), Serva (Ac-Tyr-NA for 
chymotrypsin), Boehringer-Mannl~eim (Bz-Arg-NA for trypsin), 
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Fill, 1, Structure of compounds I -3 CA) and postulated mechanism for the inhibition (B), 
K;~bi Vitrum (S-2251 for plasmin and S-2238 for thrombin), PNA 
and NPGB were from Sigma', Z.Ala.Ala.Pro-Aala.Ala.ONp was a 
kind gift from Dr J, Bietl~ (Universit~ Louis Pasteur, F-67400 
lllkirch), Active-site titrations were carried out with Z-Ala-Ala-Pro- 
Aala.Ala.ONp for both elastases [141, PNA for chymotrypsin [151 
and NPGB for trypsin, plasmin and thrombin [16], N.(2-Mett~yl. 
phenyl) 3,3,difluoro.azetldin-2.one 2 was obtained from 3.bromo- 
2,2-difluoro-propanoyl chloride and o-toluidine according to the pro. 
cedure described for the preparation of N.(3.tertbutyloxycarbonyl. 
6-methylphenyl) 3,3.difluoro.azetidin.2.one I '11], N.(2.chloro- 
methylphenyl) 3,3-difluoto-azetidin.2-one3 was prepared in a similar 
way starting from 2-(tertbutyldimethylsilyloxymethyl).aniline [17], 
The amide thus obtained was cyclized to azetidin-2.one, the tertbutyl- 
dimethylsilyloxy group of which was cleaved by aqueous HF in 
CH~CN, Finally, treatment of the resulting N.(2.hydroxymethyl. 
phenyl) 3.3-difluoroazetidin-2.one by SOCI,./DMF provided the 
azetidin-2-one 3 (AA 231-1), Details of the synthesis will be reported 
elsewhere, All kinetic studies were perforr~ed using a Lambda 5 
Perkin Elmer spectrophotometer equipped with a thermostatted cell 
holder, The pH was measured before and after each run using a pH- 
stat Radiometer type TTtc equipped with a glass B electrode, 
2.2 En:~ymic activity assays 
The amidolytie activities of PPE, HI.,E, chymotrypsin, plasmin 
and thrombin were determined at 37°C towards the approprkate 
chromogenic substrata. The total assay volume was 1 m] in the 
following buffers: 0,1 M Tris (plq 8,0) for PPE; 0,1 M Tris {PH 8,0), 
0.01 °70 Brij 35 for HLE; 0,025 M sodium phosphate (pH 7,5), O, 1 M 
KCI for chymotrypsin; 0,05 M Tris (pH 7,5), 0,01 M CaC12 for tryp. 
sin; 0,1 M sodium phosphate (pH 7.3), 25°70 (v/v) glycerol for 
01asmin, and 0,05 M Tris (pH 8,0), 0,04 M NaCI, 0,1 ~/0 (v/v) PF_.G 
6000 for thrombin. The concentration of the substrate was 100 ,~M 
(80 aM for thrombin) and the enzyme concentrations were: 0,22 .aM 
(PPE), 27 nM (HLE), 0,2 .aM (chymotrypsin, plasmin), 60 aM (tryp- 
sin) and 0.03 aM (thrombin), 
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2.3, Enz, vmic ttydrolysis ~r ¢~:¢tidinones ! and 2 
PPE and HLE activities towards compounds 1 anti 2 were 
measured spectrophotometrically at pH 8,0 and 37°C in 0,1 M Tris 
buffer ((PPE]o = 3, I and 3,63 aM. respectively) anti 0,1 M Tris bur. 
far (oH 8,0), 0.010/0 (v/v) Brij 3.~ ({FILE]~ = 2,4 and I jiM, respective- 
ly). At least 7 different concentrations of the azetidinones were used, 
within the following ranges: 15-1001~M (1, PPE), 20--73 #M (!. 
HLE), 71-471 ,aM (2, PPE) and 140-700aM (2. HI.E); The ratio 
kt, at//<'M was determined From least.squares analysis of initial rates 
against initial substrata concentrations. The concentrations cf 0,;,~ 
end products were determined usin$ tl~e molar absorption ¢neffi- 
cients: 1600 M "i cm "1 at 320 nm for 1 and 920 M "~ cm "t at :300 nm 
for 2. After 90 rain incubation at pH 8,0 (0,1 M Tris) and 37"C, a 
mixture containing 40/0 (v/v) DMSO, PPE (6/~M) and 1 (500 aM) or 
2 (250 t~M) was filtered on Centricon 10 microconcentrator. The pro. 
duct of the enzymic digestion was characterited by isocratic HPLC 
(Waters model 510) ona  5 am Cs Nucleosil column (SFCC, 250 × 
20 ram) using 30-70070 (v Jr) isopropanol/water as eluent. The flow 
rate was 0,75 ml/min and the effluent was monitored at 260 nm The 
starting azetidinones I and 2 were chrontographed under the same ex- 
perimental conditions, 
2,4. Elestase inactivation procedure 
Two different methods were used to study the action of reagent 3. 
The first was the classical method of preincubatlng enzyme and in. 
hibitor and after a fixed period, or at intervals of time, small aliquots 
(lO,al) were withdrawn. HLE (l.35/zM) and PPE (3,6/zM) were 
treated at 37°C and pH 8.0 (0,1 M Tris, 5% iv/v) DMSO and for 
HLE, 0,01°70 Brij 35) with a molar excess of inhibitor over enzyme 
ranging from 10 to 100 (HLE) and 2 to 10 (PPE), The reaction was 
stopped either by dilution of aliquots (factor of 100) or by dilution 
followed by filtration at 4°C on Centricon 10 microconcentrators 
(Amicon) and washing with buffer. The samples were assayed for 
residual enzymic activity by addition to 1 ml of the appropriate stan. 
dard assay mixture (see above). Enzyme activity was expressed 
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rel~llv~l~ Io ,n ¢ l~t~c blank ¢~al~ta|ntt ~ DM$O btll wtlh~m |n. 
lllb|1~r tt~ ~t~rre~ fo+ lh~. sp~n1~n,~u, Inad lv~l i~n ~f  the ~n~tm~. T¢  
d~l,rmtn~ th~ rewr)iblc or t~r~r~tbt¢ ~harac, l~r of tl~¢ lah|bltl~n, 
fill~r~'d altq~l¢l~ of th~ r~¢lt~n mt,~lare+t w~r~, st@fed ~l 4"¢+' i'~r I~ h 
b<for~ ~heeklrq~ r<malnlnll m<li,~+Ity, In other e,spCrlm~nt~, tlw fll|ra. 
zlot'~, the ea~yn~s w~re z,rc~ted for )0 man with i M NH~OH at pH 
J,6. 25+C, ~fld f i l l~d  al!~in befor~ d.l,:rmlflation of a¢llvlly, S~in¢ 
pseude.firsl.ofder ¢~n~ant~ k.+. f~r the In~|tv~(ton ~f PP~ ~ad 
HLE b~' 3 w~r~ obl~ined from I~sl.sCW;lr~ ~n~lysis of semiioi plot~ 
of [he p~r¢.ttlaife of rsmalnlnllt aetivilx ~ll#inst lm~. This in<ubalt~n 
med~d wa~ alse~ u~ed Io ~v#lu#le the effect Of t and I on both 
+I~tsI#,~¢S tUslfllll a ratio I I)#lBb, of ~001 m~d of 3 on the actlvlII~ of 
other ~erlne prmeases In Ihe rotlowin~ conditions: trypsin (14.~M1, 
chymotrypsifl O.#~Mh plasmin (#? tiM) ~nd thron~bin (g4 nMl; 
III~¢[EI~ - 100, pH ?.~ (e,0 rot thrombin). TPC, IF rain InCubation, 
+[he S¢¢Ofld Iltethofl (Prol|ress curv~ analysis) wa~ used to determine 
more accurately th~ kht<li¢ p~r~lmelers of Ihe Inaetlvalton of PILE 
(27 nhl} and PPE (220 aM} by the inhibitor 3 (22,~=12~ #M and 
17,2~149~M, resp~ctively} at 3"PC, pH ILO, 3.~ and ~ (v/v} 
DM$O. res pecttvd~, In t he presence of chromol~enlc subsl rate S, The 
I~eneral reaclion of a serine pretense whh a mechanism,based ina¢- 
liVatOr i t  considered Io proceed a~ordinl~ to eq, ! [ll~l, wltere E is the 
enzyme, 11he inhibitor, l '  the hydrolyxed inhibitor, E-!  the aeyl en- 
zyme trod E-I the inactivated engyme, 
E+I  El ~', E-I E~I (~q, I} 
k ~ ~ ~ k+,u 
E+I"  
El and E - I  are not observed independently and k= and ks may be 
~:ombined to ~Ive the simplified expression shown In eq. 2 (line I) 
where E' I  is a steady state enxymc-inhlbitor complex formed prior 
to L-= (in this simplified scheme, k~ is neglected), Eq, 2 describes the 
competition between 1and S. The rate of change in absorbance v at 
405 nm due to the hydrolysis of the appropriate substrata (100#M) 
as compared to a c~,lv¢tle cofltainhag tile same amount of initibitor 
and substrata in buffer was directly obtained from a computer- 
assisted spectrophotometer and anmyzed according to Hart and 
O'Bricn [19}. 
KI kina~'t 
+1 ~E* I  - -  ~E- I  
E (eq. 2) 
• S ~ ES -'--* E÷P 
K., k+ 
A plot of In v versus time gave a straight line with a slope -rr, Accor- 
ding to eq, 3, a pier of lh r  versus l/[l} (l-a.), with a' = 
[S]/(Km + [S]), analyzed by statistical treatment of Wilkinson [20] 
gave a slraight line with an x intercept of I/K= and y intercept of 
l l km.¢ , ,  
l/n" = K~/kt..~t [I] (l-a') + l/ki.,~t (eq, 3) 
Standard errors for h"~ and kinact were obtained as described by 
Wilkinson. The values of K,. (2,6 and 0.14 mM for PPE and HLE, 
respectively) were determined under the following expenmentat con- 
ditions using the appropriate buffer: [PPE] = 114 nM and [Suc- 
Alaa-NA]o = 0.03-8 raM; [HLE] = 13.5 nM and [MeO-Suc-Alaz- 
Pro-VaI-NA] = 0,05-1 raM, 
2,5. Determination of  the partition ratio 
Experiments were carried out as described above using the prein- 
cubation method, with concentrations that would not totally inac. 
tivate enzyme. After 25 rain incubation at 25°C, the mixtures were 
stirred gently at 4°C for 16-17 h before determining residual activity, 
2,6, Inhibition of  [~H]elastin solubilization 
[~H]Elastin was prepared as described before [121. Three series of 
samples of 800#~ (4.44 kBq) insoluble tritiated elastin were in. 
eubated at 37°C with PPE (83 aM). At times 0.20 and 60 min after 
the beginning of this reaction, each series of samples was treated with 
inhibitor at various final concentrations ranging from 5 to 48 #M 
t1~1~1 ~-t~lume or 400 ~11. Off+ wampl~ in <~¢h ~erifs wn~ taken ho.dy 
for ~ntrtl'ullal.ion ttl~d thtr ~np~rn~tant ~ ~'~unled Cot r~dl~a<ll~ity. 
3. RESULTS AND DISCUSSION 
3.1. En~mi¢" hy¢trolysls of azetidinones I and 2 
¢.taly=¢d by PPE and HLE 
Azetidinones I and 2 are more efficiently hydrolyzed 
in  the  presence  o f  t I LE  (k~at/Km ~ 1125 M=~s " i  for  I 
and l l00M "1 ~"~ for 2) than PPE (k~. , tgm - 
340 M" J ~ ! for I mad 500 M" t s" t for 21, By scanning 
the reaction mixtt~r¢ at rellular intervals in the range 
190-400 nm, the Sl~ectra showed new absorbance peaks 
at 319 (i) and 28S (2) nm characteristic of an aniline 
moiety. In each case, isocratie reversed.phase HPLC of 
the PPE reaction mixtures showed only the formation 
of one hydrolysis product havinlt retention times of 
11,6 rain for I anti 9 rain for 2 compared with 26.6 and 
12 rain for the Sial"tin8 azetidinones, respectively 
(Fig. 2), 
3.2. Inactivation of bILE and PPE by azetidinone 3
Exposure of PPE and HLE to reagent 3 resulted in 
a time- and concentration-dependent i hibition, For 
both enzymes, the inhibition was irreversible and no 
significant recovery of enzymic activity was observed 
after elimination of the reagent, For example, the 
percentages of remaining activity for PPE treated dur- 
ing 20 rain by a ~'0.fold molar excess of reagent were 
0.1% and 0.6e/0 before and after filtration followed by 
incubation at 4'C. To analyze the kinetics of PPE and 
HLE inactivation by 3, we followed the progress curve 
of substrate hydrolysis run in a competitive fashion in 
the presence of a concentration of inhibitor which 
causes first.order enzyme inactivation (Fig. 3A, B). 
Ti~e apparent dissociation constant of the 
enzyme-inhibitor complex Kt and the first-order cons- 
tant at infinite concentration of inhibitor ~ina¢t were ob- 
tained by analysis of changing slopes of the progress 
curves with time as described in section 2 (Fig. 3C), The 
0,20 0,20 
E 
t- 
0,15 
c.,J 
0,10 
0.o~ 
e~ 
< 
0,00  
0 
a 
i i 
10 20 
0,15 
a'  
0.10 
0,05 
' " 0 ,00  
30 40 
Time (rain,) 
Fig, 2. HPLC chromatagram of PPE hydrolysate of 1 (see section 
2.4), Peak a = 13roduct of hydrolysis of 1; peak a' = 1. 
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Fig, 3, Inactivation of HLE and PPE with reagent 3. (A and B) Time course of hydrolysis of M¢O.Suc-AIa2-Pro.VaI.NA (100/tM) by HLE 
(27 nM) (A) and of Suc-Ala~-NA (100 I,M) by PPlE (220 nM) (B) in the absence (a,a') and in the presence of various concentrations (ins,M) or 
3: (b) 22,3; (c) 3~,7; (d) 44,7; (f) 53,.6; (8) 89,3; (h) 134;0) 179; (j) 223; (b') 17,2; (¢') 28: (d') 33.6; (¢') 34,5; (f') 67,2; (g') 78,4; (h') 112; 
and (i') 149, at pH 8,0 and 37=C, (C) Determination f K= and /¢a,.,~: (e) HLE; (o) PPE, (D) Plot of the fraction of remaining activity 
(determined using the preincubation method) versus [l]/[E]o: (.) HLE; (o) PPE. 
values obtained for K~ were (2.7 ± 0.5) x 10 -4 M (PPE) 
and (1.2 ± 0.1) x 10 -4 M (HLE), and for kinac~ 0.08 ± 
0.01 s-! (PPE) and 0.035 ± 0.002 s -t (HLE) at pH 8.0 
and 37°C. 
3.3. Characteristics of the inactivation process 
The inhibitor competes with the substrata (see pro- 
gress curves); increasing amounts of substrata t fixed 
concentration of inhibitor protect the enzyme in- 
dicating that the inhibition occurs at the active site. In 
the presence of a large molar excess of azetidinones 
over enzyme (300), compounds 1 and 2 failed to inac- 
tivate both elastases, suggesting that the inactivation 
observed for their functionalized analogue 3 is not due 
to the mere formation of a stable acyl-enzyme. This 
was confirmed by the absence of reaction (<1%) 
observed when the inhibited enzymes were treated by 
buffered hydroxylamine, in agreement with an irrever- 
sible chemical modification of an enzyme amino acid 
residue different from active serine. The partition ratio 
which represents he average number of enzyme 'turn- 
overs per inactivation' /Ceat/kinact (eq. 4) was evaluated 
by the titration method [18] (Fig. 3D). 
380 
E+I  ~ E*I knac,, E- I  (eq, 4) 
J, Real 
E+I '  
The linear plot of [E]/[E]o at infinite time versus 
[I]0/[E]o is described by eq. 5 [21] and its intercept with 
the x axis minus 1 [18] gives partition ratios of  ll and 
18 for PPE and HLE, respectively. 
kinact + kcat 
[l]o/[E]o - (1 - [E]/[E]o) (eq. 5) 
~inagt 
A catalytic step prior to inactivation by 3 as pxoposed 
in the postulated mechanism (Fig. 1) is supported by 
the observed hydrolysis of the unfunctionalized 
azetidinones 1 and 2 suggesting an attack of the #- 
laetam carbonyl group by active serine. Several factors 
contribute to the high reactivity of azetidinone 3: the 
ring strain, the polarization of theZ-laetam carbonyl by 
the gem-difluoro group which, through its inductive f- 
fect, should decrease the pK of the conjugated acid of 
the aniline leaving group [11,22]. The formation of the 
aeyl-enzyme simultaneously unmasks a benzyl halide 
possessing a strong electron-releasing amino substi- 
Volume 282, number 2 FEBS LETTERS May I991 
tuent  in the ortho position, A fast e l iminat ion  o f  X" 
should llive a very electrophilic quinonimmonlum 
mezhide ion [13]. Owinlt to the cyclic nature or the in- 
Ifibitor. this electrophile is tethered by a covalent 
l inkage in the act ive  s ite durlnl~ the l i fet ime o f  the acyl 
enzyme. Then, by reaction of the electrophile with 
another active site nucleophile, an inactivated doubly- 
linked enzyme may result as reported in other cases 
[23]. The ICso value (concentration or 3 that gives 50% 
inhibition 2 rain after mixing enzyme and inhibitor) 
was found equal to 0,01 mg/ml (a value or 0,01/~/ml 
was found for other monocyclic d.lactams [10]). HLE 
is inhibited less efficiently (factor of 3,4) by 3 than by 
a bromo enol lac tone  [24] but this reagent  also inhibits 
chymotryps in .  Interest ingly ,  the inh ib i tor  3 does not 
show significant eff ic iency to inhibit chymotrypsin, 
trypsin, plasmin and thrombin ([I]o/[E]o = 100), 
:300~0 
2OOOO 
1 O000 -
0 , 
e 
E+~+I 
LJJ 
O3 
20O00 
10000 ~ 
0 - i • ! • 
1 2 
E+'S 1' 
÷1 
30000 
~J  .-r 
CO 
20000 - 
10000 - 
0 , i i 
° i 2 3 , ; 
A E+S Time (hours) 
+1 
Fig. 4. [3H]Elastin solubilization (800~g) by PPE (83 nM) in the 
absence (r~) and in the presence of reagent 3: (X) 5 aM; ( l )  16/zM; 
(+1 48 ,~M, The inhibitor was added after various times of incubation 
of PPE with elastin: (A) 0, (B) 20 and (C) 60 rain, 
3.4. Inhibition o/ elasttn soh~bili=ation 
The solubiliz~tion of [~Hlelastin by PPE  is inh ib i ted 
by 3 as shown in Fill. 4. The  values round for lC~o 
determined from a plot of v/va versus molar excess 
[ I]o/[E] (v and  vo are  the lysis rates wi th  and without  in- 
h ib i tor ,  respectively) were only decreased by a factor of 
1.6 and  2,3, respect ively,  when e lastase and  elast in were 
preincubated 20 and 60 mln before treatment by the in- 
hibitor, This interest ing feature may be of  therapeut ica l  
value,  
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